Metagenomi Inc banner
M

Metagenomi Inc
NASDAQ:MGX

Watchlist Manager
Metagenomi Inc
NASDAQ:MGX
Watchlist
Price: 1.34 USD 5.93%
Market Cap: $50.4m

Wall Street
Price Targets

MGX Price Targets Summary
Metagenomi Inc

Wall Street analysts forecast MGX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MGX is 9.52 USD with a low forecast of 7.07 USD and a high forecast of 12.6 USD.

Lowest
Price Target
7.07 USD
428% Upside
Average
Price Target
9.52 USD
610% Upside
Highest
Price Target
12.6 USD
840% Upside
Metagenomi Inc Competitors:
Price Targets
RCKT
Rocket Pharmaceuticals Inc
128% Upside
BTBT
Bit Digital Inc
307% Upside
DXPE
DXP Enterprises Inc
1% Upside
SDGR
Schrodinger Inc
105% Upside
RYI
Ryerson Holding Corp
41% Upside
SUPN
Supernus Pharmaceuticals Inc
24% Upside

Revenue
Forecast

14% / Year
Past Growth
-7% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
14% / Year
Past Growth
-7% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 3 years the compound annual growth rate for Metagenomi Inc's revenue is 14%. The projected CAGR for the next 3 years is -7%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MGX's stock price target?
Price Target
9.52 USD

According to Wall Street analysts, the average 1-year price target for MGX is 9.52 USD with a low forecast of 7.07 USD and a high forecast of 12.6 USD.

What is Metagenomi Inc's Revenue forecast?
Projected CAGR
-7%

For the last 3 years the compound annual growth rate for Metagenomi Inc's revenue is 14%. The projected CAGR for the next 3 years is -7%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett